# Solvay account plan

> Solvay is a Belgian essential chemistry group (soda ash, peroxides, silica, rare earths): €4,262m 2025 underlying net sales, ~8,400 employees.

## At a glance

Solvay SA is the Belgian "Essential Chemistry" group left after the December 2023 spin-off of its specialty businesses into Syensqo. It makes soda ash, peroxides, bicarbonate, precipitated silica, solvents, rare earths and fluorine chemicals at 43 production sites in 41 countries, with over 80% of sales regional or local-to-local. 2025 underlying net sales were €4,262m (-9.0%), underlying EBITDA €881m (20.7% margin) and free cash flow to shareholders €350m, with ~8,400 employees. It is listed on Euronext Brussels and Paris, and Solvac (founding families) holds 30.81% of the shares.

## Business units

- **Basic Chemicals** (62% of 2025 sales): Soda Ash (26% of sales), Peroxides (22%) and Bicarbonate (14%). Seaborne soda ash prices are under pressure from Chinese overcapacity, while bicarbonate and electronic-grade peroxides reached record sales levels in Q2 2026. The Jubail (Saudi Arabia) peroxides plant was halted from mid-March 2026 by the Middle East conflict.
- **Performance Chemicals** (38% of 2025 sales): Precipitated silica (12%), Solvents and Polyamide chain (11%, including Coatis in Latin America), Rare earth (8%) and Fluorine (7%). Coatis sales fell 25.6% in 2025 on Asian competition and US tariffs before rising 9.8% in Q2 2026; rare earths are more or less half of Special Chem.

## Strategic priorities

- **Structural cost savings**: €101m of savings in 2025 and €211m cumulated since 2024, with about €300m expected by end-2026 and a €350m target by 2028; Corporate run-rate below €50m from 2028.
- **Plant digitalisation and simplification**: 4,500+ plant sensors deployed with 9,000 targeted by 2027, a new ERP and a Target Operating Model, with c. €90m of transformation expenses in 2026.
- **Footprint optimisation**: Torrelavega soda ash capacity cut from 600 to 420 kilotons from Q3 2026, after peroxides closures in Portugal and Warrington and a group-wide stop of TFA.
- **Rare earths for European magnets**: NdPr oxides at La Rochelle, heavy rare earth (dysprosium and terbium) separation from autumn 2026, and €50-100m of staged investment to serve up to 30% of the European permanent-magnet market.
- **Decarbonisation**: Scope 1 & 2 emissions of 6.4 Mt CO2eq are -29% vs 2021 against a -30% 2030 target, with coal phase-out at Dombasle and Torrelavega and €25-35m a year of energy-transition capex for 2026-2030.
- **Balance sheet discipline**: Capex capped at €300m, a stable-to-increasing dividend and an investment-grade rating (S&P BBB-).

## Latest results

In H1 2026 underlying net sales were €2,028m (-8.8%, -8.0% organic) and underlying EBITDA €406m (-15.5%), a 20.0% margin. Q2 EBITDA was €187m (18.1% margin), with about €20m lost to the Jubail peroxides plant halt caused by the Middle East conflict. Soda ash prices kept weakening, while bicarbonate was steady and electronic-grade peroxides grew strongly. Free cash flow to shareholders was €15m in H1 and underlying net debt rose to €1,829m (leverage 2.3x) after dividends. The 2026 guidance was confirmed: underlying EBITDA €770-850m, free cash flow of at least €200m and capex around €300m.

## Investments and deals

- **La Rochelle rare earths**: €15-20m of new investment to extend separation capacity, a Letter of Intent with Viridis for Brazilian feedstock from 2028, toward €50-100m of capex partly supported by the French state and customer pre-financing.
- **Electronic-grade peroxides**: Electronic-grade H2O2 capacity doubled at Zhenjiang (China) to serve semiconductor demand.
- **Low-carbon energy at plants**: Refuse-derived fuel at Dombasle (start 2026) and a biomass cogeneration at Torrelavega that halves CO2 by 2027.
- **Bio-circular silica**: First bio-circular silica unit at Livorno (Italy).

## Challenges and risks

- **Chinese soda ash overcapacity**: Seaborne soda ash margins are "at a trough", so Solvay signs only very short-term export contracts and produces less.
- **Middle East disruption**: The Jubail HPPO plant halt cost about €20m of Q2 2026 EBITDA; guidance assumes a restart in Q3.
- **Coatis under Asian competition**: Coatis sales fell 25.6% in 2025 on Asian competition and US tariffs.
- **Rising leverage**: Underlying net debt reached €1,829m at leverage 2.3x in H1 2026, versus 1.8x at end-2025.
- **Carbon costs**: Solvay's EU ETS position is a deficit, covered to 2030 by free allowances, old inventory and forwards; it wants free allowances extended and competitive energy access.

## What leadership says

> "healthy margins and strong cash flow despite the challenging environment" — Philippe Kehren, Chief Executive Officer, Full-year 2025 results analysts call, February 24, 2026

> "the only company outside China" — Philippe Kehren, Chief Executive Officer, Q2 2026 results analysts call, July 29, 2026, on separating all 17 rare earth elements


## Where a supplier can help

- **Plant sensors and industrial data**: The goal of 9,000 plant sensors by 2027 and a new ERP tie to the transformation programme, a fit for industrial IoT, analytics and ERP integration partners.
- **Energy transition at sites**: €25-35m a year of energy-transition capex and the coal phase-out at Dombasle and Torrelavega call for alternative fuels, cogeneration and energy-efficiency suppliers.
- **Rare earths supply chain**: The La Rochelle expansion and the Viridis feedstock deal need process equipment, logistics and offtake partners in the European magnet chain.
- **Cost reduction under capped capex**: With capex capped at €300m and a €350m savings target by 2028, offers that cut operating cost without large capex will get attention.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Annual Integrated Report 2025](https://www.solvay.com/sites/solvay_solvay/files/2026-03/Solvay_Annual%20Integrated%20Report_2025_0.pdf)

Annual report · 2026-03-24

- Solvay SA is the Belgian "Essential Chemistry" group left after the December 2023 spin-off of its specialty businesses into Syensqo: 2025 underlying net sales of €4.3bn (€4,262m, -9.0%, -6.5% organic), ~8,400 employees, 43 production sites in 41 countries, listed on Euronext Brussels and Paris.
- Two segments: Basic Chemicals (62% of sales: Soda Ash 26%, Peroxides 22%, Bicarbonate 14%) and Performance Chemicals (38%: Precipitated silica 12%, Solvents and Polyamide chain 11%, Rare earth 8%, Fluorine 7%). Over 80% of sales are regional or local-to-local.
- 2025 underlying EBITDA €881m (-16.3%, -13.4% organic), margin 20.7% (-1.8pp); free cash flow to shareholders €350m; capex €292m (of which €53m growth capex); ROCE 13.6%; net debt €1,597m, leverage 1.8x; dividend held at €2.43 gross per share.
- Pressure came from seaborne soda ash pricing (Chinese overcapacity) and Coatis in Latin America (sales -25.6%, hit by Asian competition and US tariffs); Peroxides, Bicarbonate and Special Chem grew organically, with electronic-grade peroxides growing on semiconductor demand.
- Transformation: €101m of cost savings in 2025, €211m cumulated since 2024 against a €350m target by 2028; 4,500+ plant sensors deployed (9,000 targeted by 2027); new ERP and Target Operating Model; Torrelavega soda ash adjusted, Portugal peroxides closed, TFA and its derivatives stopped group-wide by early 2026.
- Selective growth bets: electronic-grade H2O2 capacity doubled at Zhenjiang (China); NdPr rare earth oxides line inaugurated at La Rochelle, with dysprosium and terbium planned for 2026 and €50-100m of staged investment to serve up to 30% of the European permanent-magnet market; first bio-circular silica unit at Livorno (Italy).
- Climate: scope 1 & 2 emissions 6.4 Mt CO2eq, -29% vs 2021 against a -30% 2030 target; coal phase-out via refuse-derived fuel at Dombasle (start 2026) and a biomass cogeneration at Torrelavega (CO2 halved by 2027); €25-35m a year of energy-transition capex for 2026-2030.
- 2026 guidance: underlying EBITDA €770-850m, free cash flow of at least €200m net of c. €90m transformation expenses, capex capped at €300m, cumulated structural savings around €300m; financial policy is a stable-to-increasing dividend and an investment-grade rating (S&P BBB-).
- Governance: CEO Philippe Kehren, CFO and Strategy Officer Alexandre Blum, COO Lanny Duvall; chairman Pierre Gurdjian. Solvac (founding families) holds 30.81% of the shares.

### [Financial Report, Second quarter and First half 2026](https://www.solvay.com/sites/g/files/srpend616/files/2026-07/2026Q2_Financialreport_EN_0.pdf)

Interim report · 2026-07-29

- H1 2026 underlying net sales €2,028m (-8.8%, -8.0% organic) and underlying EBITDA €406m (-15.5%, -14.7% organic), margin 20.0%; Q2 net sales €1,031m (-7.4% organic) and EBITDA €187m, margin 18.1%.
- The Middle East conflict cost about €20m of Q2 EBITDA, mainly through the temporary halt since mid-March of the HPPO peroxides plant at Jubail (Saudi Arabia); the other half of the Q2 decline is a c. €20m one-off in Special Chem in Q2 2025. Exposure to the region is under 5% of revenue.
- Soda ash pricing kept weakening, especially seaborne; bicarbonate was steady and electronic-grade peroxides grew strongly; Coatis sales rose 9.8% in Q2 on better phenol and solvents pricing.
- Structural cost savings delivered another €26m in Q2; free cash flow to shareholders was €15m in H1 (€-11m in Q2) with capex of €141m.
- Underlying net debt rose to €1,829m after €254m of dividends, leverage 2.3x; ROCE 12.4%.
- Rare earths: €15-20m of new investment to extend La Rochelle separation capacity, a Letter of Intent with Viridis for Brazilian feedstock, and industrial-scale dysprosium and terbium separation from autumn 2026.
- Torrelavega (Spain) soda ash capacity to fall from 600 to 420 kilotons from Q3 2026, refocusing on local soda ash customers and low-carbon high-grade bicarbonate.
- 2026 guidance confirmed, assuming the Saudi plant restarts in Q3: underlying EBITDA €770-850m, FCF of at least €200m net of c. €90m transformation expenses, capex around €300m, cumulated structural savings around €300m.

### [Solvay second quarter 2026 results, analysts call transcript](https://www.solvay.com/sites/g/files/srpend616/files/2026-07/2026Q2%20Transcript%20with%20Q%26A%20for%20Webpage.pdf)

Executive talk · Philippe Kehren, Chief Executive Officer · 2026-07-29

- CEO Philippe Kehren and CFO Alexandre Blum on Q2 2026 (July 29, 2026): Bicarbonate and electronic-grade Peroxides are "at record sales levels", while soda ash stays under competitive pressure in export markets.
- The Middle East conflict cost around €20m of Q2 EBITDA, mainly the shutdown of the Jubail (Saudi Arabia) peroxides plant, which supplies hydrogen peroxide by pipe to the Sadara platform; restart is being prepared for the second part of Q3 and underpins the confirmed €770-850m EBITDA guidance.
- Rare earths: Solvay claims to be "the only company outside China" able to separate all 17 rare earth elements; €15-20m more for heavy rare earths at La Rochelle (DyTb from fall 2026), a Viridis LOI for Brazilian feedstock from 2028, and an end goal of €50-100m of capex, partly French-state supported and customer pre-financed.
- Rare earths are "more or less half of Special Chem", 8% of group sales; magnet customers (autos, wind turbines, aerospace) sign multiyear contracts with committed volumes and prices.
- Soda ash: Chinese overcapacity hits seaborne prices and US exporters (which export 50% of capacity), but no Chinese soda ash reaches Europe; Solvay's European sites remain among the lowest-cost delivered to their domestic market.
- Transformation spending is kept despite the downturn: c. €90m in 2026 and about €50m in 2027; net debt €1.8bn with leverage above 2x, expected back around 2x at year-end; S&P confirmed BBB- in June.
- Kehren welcomes the EU's draft ETS reform as moving "in the right direction" and says the company is reviewing its portfolio of assets and businesses for efficiency or reinforcement.

### [Solvay fourth quarter and full year 2025 results, analysts call transcript](https://www.solvay.com/sites/g/files/srpend616/files/2026-02/2025Q4%20Transcript%20with%20Q%26A%20for%20Webpage.pdf)

Executive talk · Philippe Kehren, Chief Executive Officer · 2026-02-24

- CEO Philippe Kehren and CFO Alexandre Blum on full-year 2025 (February 24, 2026): "healthy margins and strong cash flow despite the challenging environment" — EBITDA €881m, margin close to 21%, free cash flow €350m.
- Three messages: deliver; protect competitiveness through energy transition and footprint optimisation; keep deploying the "essential chemistry" strategy (simplification, plant digitalisation, selective investment).
- Footprint: Torrelavega (Spain) soda ash capacity to be cut from 600 to 420 kilotons from Q3 2026, after fluorine restructuring in Germany, the Salindres closure and peroxides closures at Warrington (UK) and Povoa (Portugal); the cut capacity served seaborne exports and is "no regret".
- Structural savings €101m in 2025, €211m cumulated, about €300m expected by end-2026; Corporate run-rate below €50m from 2028 once the Target Operating Model is in place.
- 2026 guidance: EBITDA €770-850m, FCF above €200m after €90m of transformation expenses, capex limited to under €300m "until the environment improves"; no rapid improvement expected in soda ash or Coatis.
- Policy: wants EU ETS aligned on the 2050 target, free allowances extended, and competitive energy access; Solvay's ETS position is a deficit, covered to 2030 by free allowances, old inventory and forwards.
- Soda ash: Europe resilient with limited price pressure; seaborne margins "at a trough" from Chinese overcapacity, so Solvay signs only very short-term export contracts and produces less.
- Rare earths: active talks with buyers and policymakers in Europe and the US, including on floor prices; heavy rare earth separation at La Rochelle starts later in 2026.

## Questions about Solvay

### What does Solvay do?

Solvay produces essential chemicals such as soda ash, peroxides, bicarbonate, precipitated silica, solvents, rare earths and fluorine products, mostly for regional or local customers.

### What is Solvay's revenue?

2025 underlying net sales were €4,262m with underlying EBITDA of €881m. H1 2026 underlying net sales were €2,028m.

### How many employees does Solvay have?

Solvay has ~8,400 employees and 43 production sites in 41 countries.

### Who leads Solvay?

Philippe Kehren is CEO, Alexandre Blum is CFO and Strategy Officer, and Pierre Gurdjian chairs the board.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
